Key Takeaways
- DKNG shares declined approximately 10% on Wednesday, settling near $22.52 with trading volume down 82% from typical levels
- Investor sentiment soured following news of a Senate betting bill perceived as detrimental to the company’s prospects
- The NCAA launched legal action against DraftKings seeking to prevent the use of “March Madness” branding during the crucial tournament betting window
- The company had earlier reduced its 2026 revenue forecast to $6.5â6.9B, falling more than $600M below analyst expectations
- Despite recent setbacks, Wall Street maintains a “Moderate Buy” rating with an average price target of $37.09, representing significant upside from current trading levels
Shares of DraftKings (DKNG) closed Wednesday’s session hovering around $22.52, marking a decline of approximately 10% for the day.
The sharp selloff stems from a dual blow to investor confidence. Market participants responded negatively to developments surrounding a Senate betting bill, while simultaneously the NCAA initiated legal proceedings aimed at preventing the company from leveraging tournament branding including the iconic “March Madness” phrase.
The legal challenge from the NCAA arrives at an especially inopportune moment. Filing during the heart of tournament seasonâa critical revenue-generating window for sports wagering platformsâthe lawsuit threatens to constrain promotional efforts and potentially impact near-term earnings. Any court-imposed restrictions on marketing materials could hamper the company’s ability to capitalize on this peak betting period.
Trading activity on Wednesday registered just above 2.8 million shares, representing an 82% decline from the typical daily average of 15.6 million. Such diminished liquidity can exaggerate price swings in both upward and downward directions.
This latest setback adds to what has been a challenging year for DKNG in 2026. Management previously shocked markets by projecting full-year revenue between $6.5 and $6.9 billionâa forecast that came up more than $600 million short of analyst consensus estimates. The stock absorbed a mid-teens percentage decline following that disclosure and has struggled to regain momentum.
Revenue Outlook Disappoints Despite Impressive 2025 Performance
The conservative guidance proved particularly jarring considering the company’s stellar Q4 2025 results. Revenue reached approximately $1.99 billion, representing 43% growth versus the prior year. Adjusted EBITDA surged to roughly $620 million for the full yearâmore than triple the previous periodâand the company achieved positive net income for the first time in its history.
DraftKings essentially delivered the profitability milestone investors had long anticipated, only to temper expectations for the road ahead. This contradiction effectively reset the growth story entering 2026.
The stock currently trades well beneath both its 50-day moving average of $26.39 and its 200-day moving average of $32.01, illustrating the persistent downward pressure following the guidance revision.
From a competitive standpoint, DraftKings has been pursuing an aggressive pricing strategy. Analysis conducted during the current March Madness tournament revealed DKNG offering the lowest average vigorish among leading operators on money-line and total wagers. While this approach helps retain and attract customers, it simultaneously compresses profit margins.
Street Remains Optimistic Despite Lowered Price Objectives
Analyst sentiment toward the stock remains largely positive. Twenty-five analysts maintain Buy ratings, while five recommend Hold positions and two suggest Sell. The consensus 12-month price target stands at $37.09ârepresenting potential upside exceeding 60% from Wednesday’s closing level.
Mizuho reduced its price objective from $46 to $44 while retaining an “outperform” designation. Stifel lowered its target from $44 to $40 but maintained a “buy” recommendation. Jefferies continues to hold a $46 price target. Wells Fargo has reaffirmed its “overweight” stance.
Regarding insider activity, Director Harry Sloan acquired 100,000 shares at $21.85 during Februaryârepresenting a $2.185 million investment signaling confidence that shares were undervalued at those levels. That purchase now trades approximately at breakeven relative to current market prices.
Insider transactions over the past 90 days show net selling of approximately 549,495 shares, though company insiders collectively maintain ownership of 47.08% of outstanding shares. Institutional investors hold 37.7% of the company.
The stock is currently trading near its 52-week low, with a market capitalization hovering around $10.63 billion and a beta coefficient of 1.67.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
